167 related articles for article (PubMed ID: 35652661)
21. Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks.
Desmet T; Brijs M; Vanderdonck F; Tops S; Simoens S; Huys I
Front Pharmacol; 2024; 15():1369508. PubMed ID: 38659588
[No Abstract] [Full Text] [Related]
22. The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries.
Németh B; Goettsch W; Kristensen FB; Piniazhko O; Huić M; Tesař T; Atanasijevic D; Lipska I; Kaló Z
Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):321-330. PubMed ID: 32500749
[TBL] [Abstract][Full Text] [Related]
23. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
[TBL] [Abstract][Full Text] [Related]
24. Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?
Chassagnol F; Marcelli G; Wagle J; Giuliani G; Traub D; Schaub V; Ruof J
Health Policy; 2020 Sep; 124(9):943-951. PubMed ID: 32622542
[TBL] [Abstract][Full Text] [Related]
25. PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT.
Banta HD
Int J Technol Assess Health Care; 2018 Jan; 34(2):131-133. PubMed ID: 29609663
[TBL] [Abstract][Full Text] [Related]
26. Health Technology Assessment (HTA) and Access Policies.
Stühlinger V
Eur J Health Law; 2020 May; 27(3):274-289. PubMed ID: 33652403
[TBL] [Abstract][Full Text] [Related]
27. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
Vreman RA; Mantel-Teeuwisse AK; Hövels AM; Leufkens HGM; Goettsch WG
Value Health; 2020 Jan; 23(1):10-16. PubMed ID: 31952664
[TBL] [Abstract][Full Text] [Related]
28. The HTA Core Model
Kristensen FB; Lampe K; Wild C; Cerbo M; Goettsch W; Becla L
Value Health; 2017 Feb; 20(2):244-250. PubMed ID: 28237203
[TBL] [Abstract][Full Text] [Related]
29. Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems.
Allen N; Pichler F; Wang T; Patel S; Salek S
Health Policy; 2013 Dec; 113(3):305-12. PubMed ID: 24176288
[TBL] [Abstract][Full Text] [Related]
30. Most important barriers and facilitators of HTA usage in decision-making in Europe.
Cheung KL; Evers SMAA; De Vries H; Levy P; Pokhrel S; Jones T; Danner M; Wentlandt J; Knufinke L; Mayer S; Hiligsmann M
Expert Rev Pharmacoecon Outcomes Res; 2018 Jun; 18(3):297-304. PubMed ID: 29303374
[TBL] [Abstract][Full Text] [Related]
31. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
[TBL] [Abstract][Full Text] [Related]
32. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
Kristensen FB; Chamova J; Hansen NW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
[TBL] [Abstract][Full Text] [Related]
33. Health technology assessment: research trends and future priorities in Europe.
Nielsen CP; Funch TM; Kristensen FB
J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
[TBL] [Abstract][Full Text] [Related]
34. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
Mittermayer R; Huić M; Mestrović J
Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
[TBL] [Abstract][Full Text] [Related]
35. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
Shah SM; Barron A; Klinger C; Wright JS
Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
[TBL] [Abstract][Full Text] [Related]
36. Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach.
van der Wilt GJ; Bloemen B; Grin J; Gutierrez-Ibarluzea I; Sampietro-Colom L; Refolo P; Sacchini D; Hofmann B; Sandman L; Oortwijn W
Int J Technol Assess Health Care; 2022 Jun; 38(1):e52. PubMed ID: 35959563
[TBL] [Abstract][Full Text] [Related]
37. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
Beletsi A; Koutrafouri V; Karampli E; Pavi E
Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
[TBL] [Abstract][Full Text] [Related]
38. The role of health technology assessment in coverage decisions on newborn screening.
Fischer KE; Grosse SD; Rogowski WH
Int J Technol Assess Health Care; 2011 Oct; 27(4):313-21. PubMed ID: 22004771
[TBL] [Abstract][Full Text] [Related]
39. European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment.
Kristensen FB; Mäkelä M; Neikter SA; Rehnqvist N; Håheim LL; Mørland B; Milne R; Nielsen CP; Busse R; Lee-Robin SH; Wild C; Espallargues M; Chamova J;
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():107-16. PubMed ID: 20030898
[TBL] [Abstract][Full Text] [Related]
40. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
